0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Rotavirus Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-29F12010
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Oral Rotavirus Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Oral Rotavirus Vaccine Market Research Report 2024

Code: QYRE-Auto-29F12010
Report
January 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Rotavirus Vaccine Market Size

The global Oral Rotavirus Vaccine market was valued at US$ 7215 million in 2023 and is anticipated to reach US$ 14890 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.

Oral Rotavirus Vaccine Market

Oral Rotavirus Vaccine Market

An oral vaccine against rotavirus infection is given to babies as part of their routine childhood vaccinations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rotavirus Vaccine.

Report Scope

The Oral Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Rotavirus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oral Rotavirus Vaccine Market Report

Report Metric Details
Report Name Oral Rotavirus Vaccine Market
Accounted market size in 2023 US$ 7215 million
Forecasted market size in 2030 US$ 14890 million
CAGR 12.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Rotarix
  • RotaTeq
  • Rotavac
  • Rotavin-M1
  • Lanzhou lamb
Segment by Application
  • Hospital
  • Vaccination Station
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oral Rotavirus Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Rotavirus Vaccine Market growing?

Ans: The Oral Rotavirus Vaccine Market witnessing a CAGR of 12.8% during the forecast period 2024-2030.

What is the Oral Rotavirus Vaccine Market size in 2030?

Ans: The Oral Rotavirus Vaccine Market size in 2030 will be US$ 14890 million.

Who are the main players in the Oral Rotavirus Vaccine Market report?

Ans: The main players in the Oral Rotavirus Vaccine Market are GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech

What are the Application segmentation covered in the Oral Rotavirus Vaccine Market report?

Ans: The Applications covered in the Oral Rotavirus Vaccine Market report are Hospital, Vaccination Station, Other

What are the Type segmentation covered in the Oral Rotavirus Vaccine Market report?

Ans: The Types covered in the Oral Rotavirus Vaccine Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.3 Market by Application
1.3.1 Global Oral Rotavirus Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Vaccination Station
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Rotavirus Vaccine Market Perspective (2019-2030)
2.2 Oral Rotavirus Vaccine Growth Trends by Region
2.2.1 Global Oral Rotavirus Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Rotavirus Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Oral Rotavirus Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Oral Rotavirus Vaccine Market Dynamics
2.3.1 Oral Rotavirus Vaccine Industry Trends
2.3.2 Oral Rotavirus Vaccine Market Drivers
2.3.3 Oral Rotavirus Vaccine Market Challenges
2.3.4 Oral Rotavirus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Rotavirus Vaccine Players by Revenue
3.1.1 Global Top Oral Rotavirus Vaccine Players by Revenue (2019-2024)
3.1.2 Global Oral Rotavirus Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Rotavirus Vaccine Revenue
3.4 Global Oral Rotavirus Vaccine Market Concentration Ratio
3.4.1 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Revenue in 2023
3.5 Oral Rotavirus Vaccine Key Players Head office and Area Served
3.6 Key Players Oral Rotavirus Vaccine Product Solution and Service
3.7 Date of Enter into Oral Rotavirus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Rotavirus Vaccine Breakdown Data by Type
4.1 Global Oral Rotavirus Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Type (2025-2030)
5 Oral Rotavirus Vaccine Breakdown Data by Application
5.1 Global Oral Rotavirus Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Oral Rotavirus Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Rotavirus Vaccine Market Size (2019-2030)
6.2 North America Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Rotavirus Vaccine Market Size by Country (2019-2024)
6.4 North America Oral Rotavirus Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Rotavirus Vaccine Market Size (2019-2030)
7.2 Europe Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Rotavirus Vaccine Market Size by Country (2019-2024)
7.4 Europe Oral Rotavirus Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Rotavirus Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Oral Rotavirus Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Rotavirus Vaccine Market Size (2019-2030)
9.2 Latin America Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Rotavirus Vaccine Market Size by Country (2019-2024)
9.4 Latin America Oral Rotavirus Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Rotavirus Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Oral Rotavirus Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Oral Rotavirus Vaccine Introduction
11.1.4 GSK Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Detail
11.2.2 Sanofi-Pasteur Business Overview
11.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Introduction
11.2.4 Sanofi-Pasteur Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.2.5 Sanofi-Pasteur Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Oral Rotavirus Vaccine Introduction
11.3.4 Merck Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Biological E. Limited
11.4.1 Biological E. Limited Company Detail
11.4.2 Biological E. Limited Business Overview
11.4.3 Biological E. Limited Oral Rotavirus Vaccine Introduction
11.4.4 Biological E. Limited Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.4.5 Biological E. Limited Recent Development
11.5 China National Biotec Group
11.5.1 China National Biotec Group Company Detail
11.5.2 China National Biotec Group Business Overview
11.5.3 China National Biotec Group Oral Rotavirus Vaccine Introduction
11.5.4 China National Biotec Group Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.5.5 China National Biotec Group Recent Development
11.6 Sinovac Biotech
11.6.1 Sinovac Biotech Company Detail
11.6.2 Sinovac Biotech Business Overview
11.6.3 Sinovac Biotech Oral Rotavirus Vaccine Introduction
11.6.4 Sinovac Biotech Revenue in Oral Rotavirus Vaccine Business (2019-2024)
11.6.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Oral Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Rotarix
    Table 3. Key Players of RotaTeq
    Table 4. Key Players of Rotavac
    Table 5. Key Players of Rotavin-M1
    Table 6. Key Players of Lanzhou lamb
    Table 7. Global Oral Rotavirus Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Oral Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Oral Rotavirus Vaccine Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Oral Rotavirus Vaccine Market Share by Region (2019-2024)
    Table 11. Global Oral Rotavirus Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Oral Rotavirus Vaccine Market Share by Region (2025-2030)
    Table 13. Oral Rotavirus Vaccine Market Trends
    Table 14. Oral Rotavirus Vaccine Market Drivers
    Table 15. Oral Rotavirus Vaccine Market Challenges
    Table 16. Oral Rotavirus Vaccine Market Restraints
    Table 17. Global Oral Rotavirus Vaccine Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Oral Rotavirus Vaccine Market Share by Players (2019-2024)
    Table 19. Global Top Oral Rotavirus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rotavirus Vaccine as of 2023)
    Table 20. Ranking of Global Top Oral Rotavirus Vaccine Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Oral Rotavirus Vaccine Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oral Rotavirus Vaccine Product Solution and Service
    Table 24. Date of Enter into Oral Rotavirus Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oral Rotavirus Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
    Table 28. Global Oral Rotavirus Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2025-2030)
    Table 30. Global Oral Rotavirus Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Oral Rotavirus Vaccine Revenue Market Share by Application (2019-2024)
    Table 32. Global Oral Rotavirus Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Oral Rotavirus Vaccine Revenue Market Share by Application (2025-2030)
    Table 34. North America Oral Rotavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Oral Rotavirus Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Oral Rotavirus Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Oral Rotavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Oral Rotavirus Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Oral Rotavirus Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Oral Rotavirus Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Oral Rotavirus Vaccine Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Oral Rotavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Oral Rotavirus Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Oral Rotavirus Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Oral Rotavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Oral Rotavirus Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 49. GSK Company Detail
    Table 50. GSK Business Overview
    Table 51. GSK Oral Rotavirus Vaccine Product
    Table 52. GSK Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 53. GSK Recent Development
    Table 54. Sanofi-Pasteur Company Detail
    Table 55. Sanofi-Pasteur Business Overview
    Table 56. Sanofi-Pasteur Oral Rotavirus Vaccine Product
    Table 57. Sanofi-Pasteur Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 58. Sanofi-Pasteur Recent Development
    Table 59. Merck Company Detail
    Table 60. Merck Business Overview
    Table 61. Merck Oral Rotavirus Vaccine Product
    Table 62. Merck Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 63. Merck Recent Development
    Table 64. Biological E. Limited Company Detail
    Table 65. Biological E. Limited Business Overview
    Table 66. Biological E. Limited Oral Rotavirus Vaccine Product
    Table 67. Biological E. Limited Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 68. Biological E. Limited Recent Development
    Table 69. China National Biotec Group Company Detail
    Table 70. China National Biotec Group Business Overview
    Table 71. China National Biotec Group Oral Rotavirus Vaccine Product
    Table 72. China National Biotec Group Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 73. China National Biotec Group Recent Development
    Table 74. Sinovac Biotech Company Detail
    Table 75. Sinovac Biotech Business Overview
    Table 76. Sinovac Biotech Oral Rotavirus Vaccine Product
    Table 77. Sinovac Biotech Revenue in Oral Rotavirus Vaccine Business (2019-2024) & (US$ Million)
    Table 78. Sinovac Biotech Recent Development
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oral Rotavirus Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Oral Rotavirus Vaccine Market Share by Type: 2023 VS 2030
    Figure 3. Rotarix Features
    Figure 4. RotaTeq Features
    Figure 5. Rotavac Features
    Figure 6. Rotavin-M1 Features
    Figure 7. Lanzhou lamb Features
    Figure 8. Global Oral Rotavirus Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Oral Rotavirus Vaccine Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Vaccination Station Case Studies
    Figure 12. Other Case Studies
    Figure 13. Oral Rotavirus Vaccine Report Years Considered
    Figure 14. Global Oral Rotavirus Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Oral Rotavirus Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Oral Rotavirus Vaccine Market Share by Region: 2023 VS 2030
    Figure 17. Global Oral Rotavirus Vaccine Market Share by Players in 2023
    Figure 18. Global Top Oral Rotavirus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rotavirus Vaccine as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Oral Rotavirus Vaccine Revenue in 2023
    Figure 20. North America Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Oral Rotavirus Vaccine Market Share by Country (2019-2030)
    Figure 22. United States Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Oral Rotavirus Vaccine Market Share by Country (2019-2030)
    Figure 26. Germany Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Oral Rotavirus Vaccine Market Share by Region (2019-2030)
    Figure 34. China Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Oral Rotavirus Vaccine Market Share by Country (2019-2030)
    Figure 42. Mexico Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Oral Rotavirus Vaccine Market Share by Country (2019-2030)
    Figure 46. Turkey Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Oral Rotavirus Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. GSK Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 49. Sanofi-Pasteur Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 50. Merck Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 51. Biological E. Limited Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 52. China National Biotec Group Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 53. Sinovac Biotech Revenue Growth Rate in Oral Rotavirus Vaccine Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS